DK41791A - Antibiotikum cc 1065-analoge - Google Patents

Antibiotikum cc 1065-analoge Download PDF

Info

Publication number
DK41791A
DK41791A DK041791A DK41791A DK41791A DK 41791 A DK41791 A DK 41791A DK 041791 A DK041791 A DK 041791A DK 41791 A DK41791 A DK 41791A DK 41791 A DK41791 A DK 41791A
Authority
DK
Denmark
Prior art keywords
pct
formula
date mar
compounds
sec
Prior art date
Application number
DK041791A
Other languages
English (en)
Other versions
DK41791D0 (da
DK175458B1 (da
Inventor
Paul A Aristoff
Robert C Kelly
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK41791A publication Critical patent/DK41791A/da
Publication of DK41791D0 publication Critical patent/DK41791D0/da
Application granted granted Critical
Publication of DK175458B1 publication Critical patent/DK175458B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Artificial Filaments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Amplifiers (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Television Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Stereophonic System (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Television Receiver Circuits (AREA)
DK41791A 1988-09-12 1991-03-08 Antibiotikum CC 1065-analoge DK175458B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
US24335088 1988-09-12
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits
US8903329 1989-08-07

Publications (3)

Publication Number Publication Date
DK41791A true DK41791A (da) 1991-03-08
DK41791D0 DK41791D0 (da) 1991-03-08
DK175458B1 DK175458B1 (da) 2004-11-01

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK41791A DK175458B1 (da) 1988-09-12 1991-03-08 Antibiotikum CC 1065-analoge

Country Status (14)

Country Link
US (1) US5541339A (da)
JP (1) JP3380237B2 (da)
KR (1) KR0137959B1 (da)
AT (1) ATE198335T1 (da)
AU (1) AU632288B2 (da)
CA (1) CA1340215C (da)
DE (1) DE68929275T2 (da)
DK (1) DK175458B1 (da)
FI (1) FI103668B1 (da)
GR (1) GR3035589T3 (da)
LV (1) LV12806B (da)
NO (1) NO303498B1 (da)
TW (1) TW217383B (da)
WO (1) WO1990002746A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2076465C (en) * 1992-03-25 2002-11-26 Ravi V. J. Chari Cell binding agent conjugates of analogues and derivatives of cc-1065
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
US7589180B2 (en) 2001-05-11 2009-09-15 Abbott Laboratories Inc. Specific binding proteins and uses thereof
BR0214019A (pt) 2001-11-09 2004-10-13 Boehringer Ingelheim Phamaceut Benzimidazóis úteis como inibidores de proteìna quinase
EP1529046A1 (en) * 2002-08-08 2005-05-11 Boehringer Ingelheim Pharmaceuticals Inc. Substituted benzimidazole compounds
JP2006505571A (ja) * 2002-10-15 2006-02-16 リゲル ファーマシューテイカルズ、インコーポレイテッド 置換されたインドール及びｈｃｖ阻害剤としてのその使用
US20070213374A1 (en) * 2003-07-07 2007-09-13 Merck Patent Gmbh Malonamide Derivatives
WO2005079791A1 (en) * 2004-02-12 2005-09-01 Boehringer Ingelheim Pharmaceuticals, Inc. Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
US7446195B2 (en) * 2005-08-17 2008-11-04 Schering Corporation High affinity thiophene-based and furan-based kinase ligands
EP2126127B1 (en) 2007-01-25 2016-09-28 Dana-Farber Cancer Institute, Inc. Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
CA2680854C (en) 2007-03-15 2017-02-14 Ludwig Institute For Cancer Research Treatment method using egfr antibodies and src inhibitors and related formulations
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
US9283276B2 (en) 2007-08-14 2016-03-15 Ludwig Institute For Cancer Research Ltd. Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
MX2011004625A (es) 2008-11-03 2011-07-20 Syntarga Bv Analogos cc-1065 novedosos y sus conjugados.
CA2956934C (en) 2010-04-21 2019-07-09 Syntarga B.V. Novel conjugates of cc-1065 analogs and bifunctional linkers
WO2014066400A2 (en) 2012-10-22 2014-05-01 Arnold Glazier Methods for the effective treatment of metastatic cancer
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
AU2015205574B2 (en) 2014-01-10 2019-08-15 Byondis B.V. Method for purifying Cys-linked antibody-drug conjugates
CA2937731C (en) * 2014-01-27 2019-09-24 Pfizer Inc. Bifunctional cytotoxic agents
EP3160513B1 (en) 2014-06-30 2020-02-12 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
WO2016151432A1 (en) * 2015-03-20 2016-09-29 Pfizer Inc. Bifunctional cytotoxic agents containing the cti pharmacophore

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
MX9203200A (es) * 1986-12-19 1992-09-01 Upjohn Co Analogos de cc. 1065 novedosos.

Also Published As

Publication number Publication date
JP3380237B2 (ja) 2003-02-24
LV12806B (lv) 2002-05-20
CA1340215C (en) 1998-12-15
WO1990002746A1 (en) 1990-03-22
DE68929275D1 (de) 2001-02-01
DK41791D0 (da) 1991-03-08
KR900701801A (ko) 1990-12-04
ATE198335T1 (de) 2001-01-15
TW217383B (da) 1993-12-11
NO910958L (no) 1991-05-10
KR0137959B1 (ko) 1998-05-15
DK175458B1 (da) 2004-11-01
DE68929275T2 (de) 2001-05-23
FI103668B (fi) 1999-08-13
AU4192289A (en) 1990-04-02
JPH04500664A (ja) 1992-02-06
GR3035589T3 (en) 2001-06-29
LV12806A (en) 2002-03-20
US5541339A (en) 1996-07-30
NO910958D0 (no) 1991-03-11
NO303498B1 (no) 1998-07-20
AU632288B2 (en) 1992-12-24
FI103668B1 (fi) 1999-08-13
FI911193A0 (fi) 1991-03-11

Similar Documents

Publication Publication Date Title
DK41791D0 (da) Antibiotikum cc 1065-analoge
ES2082003T3 (es) Deshidrodidemnina b.
MX9206008A (es) Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida.
BR1100989A (pt) Composto e composição de matéria
DE69130614D1 (de) Herbizide, substituierte aryl-haloalkylpyrazole
BR8606336A (pt) Derivados de pirazolina,processo para sua preparacao,composicoes inseticidas e emprego
DK0698013T3 (da) Fungicide kondenserede bicykliske pyrimidinoner
FI863836A0 (fi) Kinolinderivat.
ATE63111T1 (de) Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen.
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
BG98238A (bg) Заместени бензотиазолови производни,получаванетоим и приложението им като хербициди
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
DE69003050D1 (de) S-substituierte beta-Thioacrylamide und deren Verwendung als Mikrobizide.
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2037597B1 (es) Perfeccionamientos en o relacionados con compuestos organicos.
DE3772909D1 (de) 3-methylphthalimide.
MX9201809A (es) N-hidroxi-n-(3-(fenil 2 substituido)prop-2-enil)urea y tiourea y formulacion farmaceutica que las contiene.
DE59809344D1 (de) Disubstituierte biphenyloxazoline
ES2055700T3 (es) Mezclas bactericidas.
BR9911522A (pt) Composição artropodicida e método de controle de artrópodes em ambientes não agronÈmicos e em ambientes da saúde animal
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
ATE87314T1 (de) Platin-arzneimittel.
DE3660426D1 (de) Urea acryl derivatives
ATE3751T1 (de) Wasserloesliche polyester und polycarbonate zur verwendung als antitumorwirkstoffe.
ATE82980T1 (de) (gem-heterocyclodimethanamin-n,n')platin komplexe.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK